Erdem, S. Et Al. 2015. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.. World journal of urology , vol.33, no.10 , 1553-60.

Erdem, S., Yegen, G., Telci, D., Yildiz, I., Tefik, T., Issever, H., ... Kilicaslan, I.(2015). The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.. World journal of urology , vol.33, no.10, 1553-60.

Erdem, Selçuk Et Al. "The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.," World journal of urology , vol.33, no.10, 1553-60, 2015

Erdem, Selçuk Et Al. "The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.." World journal of urology , vol.33, no.10, pp.1553-60, 2015

Erdem, S. Et Al. (2015) . "The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.." World journal of urology , vol.33, no.10, pp.1553-60.

@article{article, author={Selçuk ERDEM Et Al. }, title={The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.}, journal={World journal of urology}, year=2015, pages={1553-60} }